Zdrowie i gospodarka · 03/11/1998

FDA Approves Supplemental New Animal Drug Application for Equine Use of Hyaluronate Sodium Injection

The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect the approval of a supplemental new animal drug application (NADA) filed by Anika Therapeutics, Inc. for the use of a hyaluronate sodium injection in horses, which contains 11 milligrams of hyaluronate sodium per milliliter, a higher concentration than the currently approved 10 mg/mL.